Abstract
dc:description.abstractDrugs used in combination therapy has superior treatment efficacy. Preclinical experimental screenings have fueled this progress by identifying and prioritizing new candidate combinations, but they lack predictive power over the transcriptomic data of individualized cancer samples in which exploration of the combination treatment space is intractable. There is an unmet need for computational modeling approaches that can accurately predict personalized synergistic drug combinations by integrating patient-specific molecular data. To overcome this limitation, we developed PAIRWISE, a novel DL framework to survey large preclinical screening dataset for drug combination modeling. Our method showed improved drug synergy prediction compared with benchmarked methods with superior sensitivity/specificity in the prediction of likely synergy. To further investigate safety of drug combination, we developed DDI-GPT, innovated with blending knowledge graph into a sentence as an input in large language model, achieves precision and accuracy in drug-drug interaction prediction.
Degree
thesis:*- Name thesis:degree_name
- Ph. D., Biomedical Engineering
- Level thesis:degree_level
- Doctor of Philosophy
- Discipline thesis:degree_discipline
- Biomedical Engineering
- Grantor
- Cornell University
- Year dc:date.issued
- 2025
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Xu, Chengqi
- Chair dc:contributor.chair
-
- Elemento, Olivier
- Committee members dc:contributor.committeemember
-
- Fischbach, Claudia
- Wang, Fei
- Yang, Qian
Rights
- Language dc:language.iso
- en
Identifiers
dc:identifier.*- Dc Identifier Bibid
- 16938302
- Dc Identifier Other
-
ProQuest Submission ID: 14802
ProQuest Publication ID: 31764968